Law Firms Making Changes To IP Staff
A number of law firms and a key trademark industry group have made changes in recent weeks aimed at boosting their intellectual property practices.
Intellectual Property Watch
Original news and analysis on international IP policy
Category Features
New Director For Free Software Foundation
The Free Software Foundation (FSF) has announced the appointment of a new executive director.
Panel: Help Needed With IP Implications Of Nagoya Protocol On Genetic Resources
The new international agreement on access and benefit-sharing of genetic resources has many IP implications, according to panellists at an event last week. And at least one United Nations agency is launching an effort to help countries with those IP implications.
In Brazil And The IP World, It’s Tropicalization Time!
Benny Spiewak writes: There used to be a time when Brazil meant almost exclusively Carnival, Samba and Soccer. Well, those days are over and there is an undeniable message that will echo through the knowledge-based, creative, innovative world: Wake-Up, World, It’s Tropicalization Time!
Former Senator To Head Motion Picture Association
The Motion Picture Association of America, the influential US film industry group, has landed a highly regarded former US senator as its next chairman and chief executive officer.
Building A Consensus To Address The Health Threat Posed By Fake Medicines
On the eve of a meeting of the WHO working group on substandard/spurious/falsely-labelled/falsified/counterfeit medical products, research-based pharmaceutical industry group IFPMA sets out thoughts on building global consensus to address fake medicines.
Pharma Lawyer Is New Deputy Director At USPTO
A Washington intellectual property lawyer and private sector representative has been named deputy director at the United States Patent and Trademark Office. Her area of expertise is pharmaceutical, biotechnology and other life science issues.
Brazil And The Defence Of Public Health: Do As I Say, Not As I Do
A recent decision issued by Advocacia-Geral da União (Advocacy-General of the Union) restricts the role performed by Anvisa - the National Agency for Health Surveillance - in examining pharmaceutical patent applications. This may represent a huge setback for commitments made by Brazilian government related to the protection of public health, writes Felipe Carvalho.
Retired US Copyright Chief On Copyright Clearance Center Board
The appointment of former United States Register of Copyrights to the board of directors of the Copyright Clearance Center (CCC) was announced yesterday.
Columbia Law Expert On Telecom, Copyright To FTC
A respected US law professor has been named senior advisor to the US Federal Trade Commission (FTC) for consumer protection and competition issues that affect the internet and mobile markets.